Literature DB >> 15150819

Wound healing and treatments for people with diabetic foot ulcers.

William J Jeffcoate1, Patricia Price, Keith G Harding.   

Abstract

The factors that delay wound healing are multiple and relate both to diabetes and to the effect of its complications. Diabetic foot ulcers readily become chronic, and chronic ulcers have biological properties that differ substantially from acute ones. Much of the available information on the biology of wound healing relates to acute and experimental wounds and may not be directly relevant. It follows that there is limited evidence currently available to underpin protocols for the management of diabetic foot ulcers, or to guide choice of applications and dressings 1. Nevertheless, it is possible to define certain principles.GLYCAEMIC CONTROL: The first relates to glycaemic control. While chronic complications of diabetes such as peripheral vascular disease and neuropathy may be largely irreversible, aspects of structure and function of connective tissue and cells may be impaired by hyperglycaemia, and their function should be improved if normoglycaemia is achieved. PROMOTION OF HEALING: The second principle concerns attempts at active promotion of wound healing by (1) surgical revascularization, and (2) specific attempts to correct defined biological abnormalities thought to be hindering the healing process. These include the use of a variety of applications, dressings and technologies, which may stimulate healing by applying, or stimulating the release of, growth factors and cytokines. While this approach holds the greatest promise for the future, it will be dependent on defining defects which need correction in specific individuals, and having technologies available to address them. This field is in its infancy. WOUND CARE: The third broad principle concerns the management of the wound and its surrounding tissue in order to promote healing. This includes regular inspection, cleansing and removal of surface debris, elimination of pathogenic bacteria and creation of an appropriate environment to facilitate endogenous tissue regeneration. There are many applications and dressings that may be chosen to promote healing, but, whichever is selected, wound management has to be integrated into an effective programme of multidisciplinary care. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15150819     DOI: 10.1002/dmrr.476

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  34 in total

Review 1.  The diabetic foot: the importance of biofilms and wound bed preparation.

Authors:  Stephen C Davis; Lisa Martinez; Robert Kirsner
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

2.  The association between surgical site infection and previous operation in oral cavity cancer patients.

Authors:  Wen-Jiun Lin; Ching-Ping Wang; Chen-Chi Wang; Rong-San Jiang; Yong-Kie Wong; Fun-Jou Chen; Shih-An Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-22       Impact factor: 2.503

Review 3.  Diabetes mellitus and burns. Part I-basic science and implications for management.

Authors:  Ioannis Goutos; Rebecca Spenser Nicholas; Atisha A Pandya; Sudip J Ghosh
Journal:  Int J Burns Trauma       Date:  2015-03-20

4.  The use of Matriderm and autologous skin grafting in the treatment of diabetic ulcers: a case report.

Authors:  Valerio Cervelli; Lucilla Lucarini; Caterina Cerretani; Diana Spallone; Ludovico Palla; Lorenzo Brinci; Barbara De Angelis
Journal:  Int Wound J       Date:  2010-06-08       Impact factor: 3.315

Review 5.  Benefit-risk assessment of becaplermin in the treatment of diabetic foot ulcers.

Authors:  Nikolaos Papanas; Efstratios Maltezos
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

6.  Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds.

Authors:  Zee Upton; Hilary J Wallace; Gary K Shooter; Derek R van Lonkhuyzen; Sim Yeoh-Ellerton; Erin A Rayment; Jacqui M Fleming; Daniel Broszczak; Douglas Queen; R Gary Sibbald; David I Leavesley; Michael C Stacey
Journal:  Int Wound J       Date:  2011-10       Impact factor: 3.315

7.  Risk factors of free flap compromise in 247 cases of microvascular head and neck reconstruction: a single surgeon's experience.

Authors:  Young-Hoon Joo; Dong-Il Sun; Jun-Ook Park; Kwang-Jae Cho; Min-Sik Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-12       Impact factor: 2.503

8.  A parallel open-label trial to evaluate microbial cellulose wound dressing in the treatment of diabetic foot ulcers.

Authors:  Douglas R Solway; William A Clark; Dennis J Levinson
Journal:  Int Wound J       Date:  2010-12-16       Impact factor: 3.315

Review 9.  Reducing the incidence of foot ulceration and amputation in diabetes.

Authors:  Cynthia L Bartus; David J Margolis
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

10.  Evidence-based management strategies for treatment of chronic wounds.

Authors:  Frank Werdin; Mayer Tennenhaus; Hans-Eberhardt Schaller; Hans-Oliver Rennekampff
Journal:  Eplasty       Date:  2009-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.